• 1
    Hopkins NH. The origin of human cancer. In: WatsonJD, HopkinsNH, RobertsJW, SteitsJA, WeinerAM, eds. Molecular Biology of the Gene, vol. 2, ed. 4. Menlo Park, CA: Benjamin/Cummings, 1987; 10581096.
  • 2
    Bos JL. Ras oncogenes in human cancer: A review. Cancer Res 1989; 49: 46824689.
  • 3
    Tada M, Omata M, Ohto M. Analysis of ras gene mutation in human malignant hepatic tumors by polymerase chain reaction and direct sequencing. Cancer Res 1990; 50: 11211124.
  • 4
    Okuda K, Kubo Y, Okazaki N et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. Cancer 1977; 39: 232246.
  • 5
    Nakajima T, Kubosawa H, Kondo Y, Konno A, Iwama S. Combined hepatocellular-cholangiocarcinoma with variable sarcomatous transformation. Am J Clin Pathol 1988; 90: 309312.
  • 6
    Tada M, Yokosuka O, Omata M, Ohto M, Isono K. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990; 66: 930935.
  • 7
    Mizumoto R, Kawarada Y. Diagnosis and treatment of cholan-giocarcinoma and cystic adenocarcinoma of the liver. In: OkudaK, IshakKG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 143158.
  • 8
    Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525532.
  • 9
    Hill MJ, Crowther JS, Drasar BS, Hawksworth G, Aries V, Williams REO. Bacteria and aetiology of cancer of large bowel. Lancet 1971; 1: 95100.
  • 10
    Nigro JM, Baker SJ, Preisinger AC et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705708.